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Neonatal Abstinence Syndrome (NAS) is a 
growing worldwide pandemic and is a 
threat to the health of diagnosed infants 
(Alemu et al., 2020). Symptoms of NAS 
include low-birth weights, difficulty 
feeding, unsoothable irritability, and 
seizures (Barfield et al., 2017). Evidence 
has shown that these impacts extend into 
childhood, negatively affecting growth and  
development (Fill et al., 2018). The purpose 
of this study is to analyze the impact of 
NAS on infants, their mothers, and the 
nurses who care for the infants. We also 
identify several effective pharmacological 
and nonpharmacological interventions to 
counteract NAS withdrawal symptoms. 
Background and Significance Conclusion
NAS is a substance-withdrawal disorder that 
impacts infants that have been exposed to 
addictive substances in utero; substances include 
methadone, buprenorphine, narcotics, opioids, 
alcohol, illegal substances, and more. NAS 
presents as respiratory distress, low birth weight, 
poor feeding, and irritability soon after birth 
(Alemu et al., 2019).
NAS across the US has increased by threefold 
since the 2000s; however, Tennessee has 
increased by tenfold (Tennessee Department of 
Health).
More than 5% of women use illicit drugs during 
pregnancy and 49-94% of infants who are 
exposed to illicit drugs or opioids experience 
NAS (Johnson, 2017). Additionally, children 
born with NAS are 3.2 times  more likely to have 
a greater number of healthcare insurance claims 
through age 8; these claims are also more costly 
(Guodong et al., 2019).
In 2016, an estimated $1.8 billion in medical 
expenses from neonatal hospitalizations resulted 
from NAS (Alemu et al., 2019).
Lawmakers across the United States feel that 
opioid abuse during pregnancy is the main 
concern; however, research supports any 
substance that is abused during pregnancy is 
harmful to a fetus and can cause an infant 
experience NAS upon birth (Woodruf & Roberts, 
2019).
In a study by Rockefeller et al. (2019), they 
analyzed the mother’s perspective. The study 
focused on their experiences with healthcare 
workers, support groups, and the obstacles they 
faced  when bonding and caring for their child. 
The NAS pandemic stems from the growing 
opioid crisis. Proper prescription of controlled 
substances, accurate surveillance of the trends of 
NAS, and available treatments for expecting 
mothers are ways the Center for Disease Control 
and Prevention (CDC) is tackling the crisis 
(Barfield et al., 2017). Standardization of 
assessing infants at risk for NAS is needed to 
provide quality care to these infants. 
Non-pharmacological methods, such as 
in-rooming, low stimulus environments, and 
breastfeeding, should be pursued before narcotic 
treatment (Barfield et al., 2017; Loyal et al., 
2019).
Methods of preventing NAS include educating 
the general public about NAS, especially 
pregnant woman who may battle substance 
abuse. Many physicians recommend prescribing 
non opioid methods of treatment for pain (Ko et. 
al, 2017). State lawmakers should also stay 
abreast of the current conditions of NAS in their 
states and work to decriminalize the situation so 
women can seek prenatal care without fear of 
being charged. 
Posters/pamphlets, speaking at SUD meetings, 
and educating mothers about NAS are ways to 
inform the general public about this growing 
crisis.
A study by Parlaman (2019) found that by 
introducing nonpharmacological treatments, the 
infant with NAS hospital stay reduced from nine 
days to six days as well as a 60% decrease in 
morphine use. Morphine use dropped from 63% 
to 23%. 
Such non-pharmacological treatments include 
in-rooming with the mother, limiting light/sound 
exposure, and not using the Finnegan tool for 
assessing NAS because this contradicts idea of  
limited stimuli (Loyal et al., 2019).
NAS is a growing pandemic, specifically in rural 
areas with high poverty rates. An example would 
be the Appalachian area of East Tennessee. This 
region experiences NAS at a rate of 28.5 per 
1,000 live births compared to the state of 
Tennessee’s rate of 12.7 per 1,000 live births 
(Erwin, 2017).
In the Rockefeller et al. study (2019) the women 
interviewed reported overwhelming support from 
healthcare professionals; however, there was a 
lack of information about NAS from them. 
Instead, the mothers gathered information from 
other mothers and support groups for NAS. 
Another study on the mother’s perspective 
reported they often felt criticized or judged by 
healthcare workers, making it more difficult for 
them to seek help when they know that they have 
a substance abuse issue (Johnson, 2017).
In an focused ethnography by Nelson (2016), 
NICU nurses expressed grief, exhaustion, and 
frustration when caring for neonates affected by 
maternal substance abuse in utero (pp. 34-74). 
Nurses also reported difficulty during 
interactions with mothers because they were 
often anxious and have complex psychosocial 
issues (Loyal et al., 2019). 
(Winkelman et. al., 2018).
The Literature Review for Neonatal Abstinence 
Syndrome (NAS)  analyzed 20 articles on the 
topic of NAS and the effects on mothers, infants, 
and nurses. 
Pubmed and CINAHL were used to collect 
articles written within the past five years.
